Medtronic to test wider CRT (cardiac resynchronisation therapy) use in major study
This article was originally published in Clinica
Executive Summary
In what could expand the use of device-based cardiac resynchronisation therapy (CRT) for heart failure, Medtronic is to begin a major study to assess whether the technique can help limit the progression of the disease in patients who have mild or even no heart failure symptoms.